secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2026-06-22T13:05:10+00:00
Accession:  0001493152-26-029517
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Fertility Q1 revenue up 23% to $2.0M; net loss widens on warrant charge, balance sheet strengthened
--------------------------------------------------------------------------------

- Revenue $2.02M (+23% YoY); clinic revenue $1.98M (+22%) driven by organic growth and Family Beginnings acquisition.
- Net loss from continuing ops $5.5M (incl. $3.8M non-cash warrant remeasurement) vs $1.5M prior year.
- Adjusted EBITDA -$1.26M vs -$0.6M; investments in personnel and infrastructure for future clinic expansion.
- Eliminated all Series C-2 Preferred ($2.4M) and warrant liabilities ($1.9M); cash rose to $4.9M from $2.1M at Dec 2025.
- Stockholders' equity more than doubled to $15.0M (108% increase); total liabilities down 26% to $9.6M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226029517/0001493152-26-029517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315226029517/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer